← Browse by Condition
Medical Condition

resectable pancreatic adenocarcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06816914 Phase 2
Recruiting

Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial

Enrollment
84 pts
Location
Taiwan
Sponsor
Taichung Veterans General Hosp...
View Trial →